Canada
Search    
Include All CSL Behring Country Sites

News Room

The most recent items of news in the Canadian Region are:

04/12/2018
LIFE-SAVING MEDICINES DONATED FOR PATIENTS IN THE DEVELOPING WORLD
Ottawa – CSL Behring has shipped more than 10 million international units (IUs) of its medicines to treat hemophilia A to the WFH Global Alliance for Progress (GAP)Program in recognition of World Hemophilia Day. More.

03/01/2018
Rare Disease Day February 28th 2018
Ottawa – CSL Behring Canada staff raise and join their hands in support of patients with Rare Disease. Raise and Join your hands for Rare Disease Day February 28th 2018. More.

08/09/2017
Berinert® Approved by Health Canada for the Treatment of Hereditary Angioedema (HAE) in Pediatric Patients.
CSL Behring is pleased to announce that on March 31st, 2017 Berinert (C1 Esterase Inhibitor, Human) was approved by Heath Canada for Pediatric Hereditary Angioedema (HAE). More.